Side-by-side comparison of AI visibility scores, market position, and capabilities
Global sneaker retail chain with $8B revenue executing Lace Up plan; diversifying from Nike dependency with New Balance and HOKA while renovating Power Stores under Mary Dillon.
Foot Locker is a global specialty athletic footwear and apparel retailer operating approximately 2,500 stores across 26 countries under the Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos banners. Founded in 1974 as a spinoff from Woolworth Corporation and listed on NYSE, Foot Locker generates approximately $8 billion in annual revenue and holds a unique position in sneaker culture — its mall-based stores and striped referee uniforms have been part of sneaker retail since basketball culture and Nike/Jordan brands elevated sneakers to cultural objects.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.